Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “TTR Cardiac Amyloidosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03294707
What this trial is testing

Single and Multiple Ascending Dose Study Assessing the Safety, Tolerability, PK and PD of AG10

Who this might be right for
Amyloid Cardiomyopathy, Transthyretin-Related
Eidos Therapeutics, a BridgeBio company 56
Testing effectiveness (Phase 2)Study completedNCT01981837
What this trial is testing

Phase 2 Study to Evaluate ALN-TTRSC (Revusiran) in Patients With Transthyretin (TTR) Cardiac Amyloidosis

Who this might be right for
TTR-mediated Amyloidosis
Alnylam Pharmaceuticals 26
Testing effectiveness (Phase 2)Study completedNCT02016365
What this trial is testing

Safety and Efficacy Study of Doxycycline/UrsoDeoxyCholicAcid on Disease Progression in ATTR Amyloidosis

Who this might be right for
Transthyretin AmyloidosisCardiomyopathy
Umeå University 55
Not applicableStudy completedNCT03842163
What this trial is testing

Prevalence and Characteristics of Transthyretin Amyloidosis in Patients With Left Ventricular Hypertrophy of Unknown Etiology

Who this might be right for
Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)
Pfizer 812
Not applicableLooking for participantsNCT06251778
What this trial is testing

NatiOnal Referral cenTEr Study of Transthyretin Amyloid Cardiomyopathy(ATTR) Patients on Tafamidis

Who this might be right for
AmyloidosisAmyloidosis CardiacATTR Amyloidosis Wild Type
Paolo Milani 200
Not applicableStudy completedNCT01432587
What this trial is testing

The Effect of Diflunisal on Familial Transthyretin Amyloidosis

Who this might be right for
Amyloidosis
Umeå University 55
Not applicableStudy completedNCT04828928
What this trial is testing

Neuropathy in Patients Monitored for Wild-type TTR Cardiac Amyloidosis (Non-mutated)

Who this might be right for
Wild-type Amyloid Cardiopathy
University Hospital, Bordeaux 65
Not applicableStudy completedNCT06261216
What this trial is testing

Association Between Lifetime Physical Activity and Exercise and the Development of Wild-type Transthyretin Amyloid Cardiomyopathy

Who this might be right for
Amyloid CardiomyopathyWild Type ATTR Amyloidosis
Medical University of Graz 180
Not applicableLooking for participantsNCT07215715
What this trial is testing

US Benchmarking Clinical Study

Who this might be right for
HFpEF - Heart Failure With Preserved Ejection FractionHFmrEFATTR-CM (Transthyretin Amyloid Cardiomyopathy)+2 more
eMyosound SAS 150
Not applicableUnknownNCT04563286
What this trial is testing

Patient-Reported Outcome Measures in Wild-Type and Variant Cardiac Transthyretin Amyloidosis

Who this might be right for
Transthyretin Amyloidosis
University of Messina 250
Not applicableStudy completedNCT03588468
What this trial is testing

Expanding the Biomarkers in Familial Amyloid Neuropathy: MRI and Motor Unit Estimation by Electrophysiological Study

Who this might be right for
Amyloid NeuropathiesTransthyretin Amyloidosis
Assistance Publique Hopitaux De Marseille 60
Very early researchStudy completedNCT03414632
What this trial is testing

Transthyretin Cardiac Amyloidosis in HFpEF

Who this might be right for
Heart Failure With Preserved Ejection Fraction
Mayo Clinic 287
Early research (Phase 1)Study completedNCT04360434
What this trial is testing

First-in-Human Study of NI006 in Patients With Amyloid Transthyretin Cardiomyopathy

Who this might be right for
Amyloid Transthyretin Cardiomyopathy
Neurimmune AG 46
Not applicableEnded earlyNCT03328338
What this trial is testing

Mitochondrial Function in Transthyretin Amyloidosis

Who this might be right for
Cardiac Amyloidosis
University Hospital Center of Martinique 12
Not applicableUnknownNCT06101108
What this trial is testing

Early Diagnosis of Age-Linked CArdiac TransThyRetin Amyloidosis by Selective Screening in Spinal Stenosis Surgery

Who this might be right for
Transthyretin Amyloid Cardiomyopathy
Philippe Debonnaire 400
Testing effectiveness (Phase 2)Active Not RecruitingNCT07608354
What this trial is testing

Evaluate the Efficacy and Safety of Concomitant Use of Eplontersen and ALXN2220 Compared With Eplontersen and Placebo for Adults Participants With ATTR-CM

Who this might be right for
Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
AstraZeneca 326
Not applicableStudy completedNCT03322319
What this trial is testing

Frequency of Cardiac Amyloidosis in the Caribbean's. (TEAM Amylose)

Who this might be right for
Left Ventricular Hypertrophy
University Hospital Center of Martinique 175
Testing effectiveness (Phase 2)Looking for participantsNCT06318260
What this trial is testing

Haemodynamic Effects of Dobutamine in Patients With Wild-type Transthyretin Amyloid Cardiomyopathy (ATTRwt)

Who this might be right for
ATTR Amyloidosis Wild Type
Steen Hvitfeldt Poulsen 15
Large-scale testing (Phase 3)Active Not RecruitingNCT06183931
What this trial is testing

Study of ALXN2220 Versus Placebo in Adults With ATTR-CM

Who this might be right for
Transthyretin Amyloid Cardiomyopathy
Alexion Pharmaceuticals, Inc. 1,181
Post-approval studies (Phase 4)Looking for participantsNCT07695701
What this trial is testing

Cardiac Magnetic Resonance and Echocardiography Study With Acoramidis

Who this might be right for
Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)AmyloidosisAmyloid Cardiomyopathy+1 more
Eidos Therapeutics, a BridgeBio company 150
Next Page